Vimarsana
Biggest News Aggregation in the World

Page 12 - Gate Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gate Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gate Manager Today - Breaking & Trending Today

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) Releases FY 2026 Earnings Guidance - Vimarsana News

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) Releases FY 2026 Earnings Guidance

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI – Get Free Report) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided EPS guidance of 2.890-2.890 for the period. The company issued revenue guidance of -. Hannon Armstrong Sustainable Infrastructure Capital Trading Up 2.8 % Shares of HASI stock opened at $26.24 […]

Source: wkrb13.com
Sorrento Therapeutics (NASDAQ:SRNE) Share Price Crosses Below Two Hundred Day Moving Average of $0.10 - Vimarsana News

Sorrento Therapeutics (NASDAQ:SRNE) Share Price Crosses Below Two Hundred Day Moving Average of $0.10

Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.10 and traded as low as $0.02. Sorrento Therapeutics shares last traded at $0.05, with a volume of 956,943 shares trading hands. Wall Street Analysts Forecast […]

Source: wkrb13.com
Nova (NASDAQ:NVMI) Updates Q1 2024 Earnings Guidance - Vimarsana News

Nova (NASDAQ:NVMI) Updates Q1 2024 Earnings Guidance

Nova (NASDAQ:NVMI – Get Free Report) updated its first quarter 2024 earnings guidance on Friday. The company provided earnings per share guidance of 1.210-1.330 for the period, compared to the consensus earnings per share estimate of 1.190. The company issued revenue guidance of $134.0 million-$140.0 million, compared to the consensus revenue estimate of $134.0 million. […]

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […]

Nova (NASDAQ:NVMI) Updates Q1 Earnings Guidance - Vimarsana News

Nova (NASDAQ:NVMI) Updates Q1 Earnings Guidance

Nova (NASDAQ:NVMI – Get Free Report) issued an update on its first quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.21-1.33 for the period, compared to the consensus earnings per share estimate of $1.19. The company issued revenue guidance of $134-140 million, compared to the consensus revenue estimate of […]